Reported 1 shares, unchanged from the prior quarter.
Reported value -16.7%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2024-03-31 | 22 |
| 2024-06-30 | 12 |
| 2024-09-30 | 10 |
| 2024-12-31 | 7 |
| 2025-03-31 | 8 |
| 2025-06-30 | 5 |
| 2025-09-30 | 13 |
| 2025-12-31 | 18 |
| 2026-03-31 | 15 |
| 2026-06-30 | 18 |
| 2026-09-30 | 15 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $15 | 2026-11-03 | |
| Q2 2026 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $18 | 2026-08-05 | |
| Q1 2026 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $15 | 2026-05-07 | |
| Q4 2025 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $18 | 2026-02-11 | |
| Q3 2025 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $13 | 2025-11-13 | |
| Q2 2025 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $5 | 2025-07-08 | |
| Q1 2025 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $8 | 2025-04-08 | |
| Q4 2024 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $7 | 2025-02-10 | |
| Q3 2024 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $10 | 2024-11-13 | |
| Q2 2024 | Unchanged | 1 | 0 (0.0%) | < 0.01% | $12 | 2024-08-08 | |
| Q1 2024 | New | 1 | +1 (0.0%) | < 0.01% | $22 | 2024-05-06 |
Who else reported the position
161 managers reported AVALO THERAPEUTICS INC COM PAR for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| FMR LLC | Added | 5,250,181 | +149,965 | < 0.01% | $80,485,275 | 4 qtrs |
| BlackRock Inc | Added | 4,959,604 | +594,051 | < 0.01% | $76,030,730 | 9 qtrs |
| FARALLON CAPITAL MANAGEMENT LLC | Added | 3,974,000 | +1,476,000 | 0.26% | $60,921,420 | 3 qtrs |
| Deep Track Capital LP | Unchanged | 3,610,000 | 0 | 0.9% | $55,341,300 | 2 qtrs |
| Caligan Partners LP | Added | 3,268,303 | +104,437 | 3.07% | $50,103,085 | 5 qtrs |
| Affinity Asset Advisors LLC | Added | 3,244,861 | +344,861 | 2.02% | $49,743,719 | 11 qtrs |
| TCG Crossover Management LLC | Unchanged | 3,017,120 | 0 | 1.31% | $46,252,450 | 9 qtrs |
| STATE STREET CORPORATION | Reduced | 2,563,226 | -326,061 | < 0.01% | $39,294,255 | 5 qtrs |
| Avoro Capital Advisors LLC | Added | 2,377,777 | +44,444 | 0.38% | $36,451,321 | 3 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 2,256,245 | -8,001 | < 0.01% | $34,588,236 | 3 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 03, 2026
- Filing type
- 13F-HR
- Position type
- Stock
Voting authority reported
- Sole
- 0
- Shared
- 0
- None
- 1
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.